Zacks.com on MSN3d
ResMed Gains 37.8% in a Year: What's Driving the Stock?RMD's shares gain on the back of robust mask and device sales growth. However, the unfavorable macroeconomic scenario is ...
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief ...
Shares of ResMed Inc. RMD advanced 1.40% to $231.67 Friday, on what proved to be an all-around positive trading session for ...
Shares of ResMed Inc. RMD dropped 0.09% to $228.48 Thursday, on what proved to be an all-around rough trading session for the ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an update.
ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians: Our Bureau, Bengaluru Monday, January 6, 2025, 17:30 Hrs [IST] ResMed, the world’s leading he ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an update.
Goldman Sachs has a buy rating and $36.20 price target on Woolworths' shares. Analysts at Catapult Wealth are positive on ...
Highlights,ResMed's stock price dips below its 200-day moving average.,The company posted strong quarterly earnings, ...
Barchart on MSN3d
ResMed's Quarterly Earnings Preview: What You Need to KnowBased in San Diego, California, ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback